Essa, A; Mohamed Ibraheem, K.I; Elimam, H; Elnaidany, N; Shehab-Eldeen, S; Abdu Allah, A.M; Sabry, A; Abbasy, M; Nada, A
(Hindawi Limited, 2020)
Background. Direct-acting antivirals (DAAs) made a drastic change in the management of HCV infection. Sofosbuvir is one of the highly potent DAAs, eliminated mainly through the kidney. But concerns about renal safety during ...